top of page

THE NEED FOR SPEED

EpiVax Therapeutics developed a game-changing neoantigen personalized cancer vaccine proprietary process with an accelerated biopsy-to-needle timeline of under 4 weeks 

Biopsy-to-Needle Process (1).JPG

Subscribe Form

Thanks for submitting!

  • LinkedIn
  • YouTube

©2023 by EpiVax Therapeutics, Inc.

bottom of page